The synthesis and antibacterial activity of 1,3,4-thiadiazole phenyl oxazolidinone analogues.

doi:10.1016/J.BMCL.2003.07.018

Paper

DOI: 10.1016/J.BMCL.2003.07.018

The synthesis and antibacterial activity of 1,3,4-thiadiazole phenyl oxazolidinone analogues.

Published Dec 1, 2003 · L. M. Thomasco, R. Gadwood, E. Weaver

Bioorganic & medicinal chemistry letters

Q2 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Study Snapshot

This study demonstrates that 1,3,4-thiadiazole phenyl oxazolidinone analogues with morpholine C-ring replacement and thioacetamide group conversion show potent antibacterial activity against both gram-positive and gram-negative organisms.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Full text analysis coming soon...

References

DOI: 10.1086/324525

Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.

Antimicrobial resistance rates among respiratory pathogens vary significantly by region, with significant variation in penicillin-resistant S. pneumoniae and beta-lactamase production among H. influenzae and M. catarrhalis.

2002·217citations·C. Thornsberry et al.·Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

DOI: 10.1016/S0195-6701(01)90031-3

Therapeutic options for Gram-positive infections.

Linezolid is a new agent developed to help treat Gram-positive infections, especially in areas with high resistance, while future agents like oritavancin, daptomycin, and glycylcyclines are in development.

2001·11citations·M. Rybak·The Journal of hospital infection

The Journal of hospital infection

DOI: 10.1016/S0968-0896(01)00233-4

Carbon-carbon-linked (pyrazolylphenyl)oxazolidinones with antibacterial activity against multiple drug resistant gram-positive and fastidious gram-negative bacteria.

Carbon-carbon-linked pyrazolylphenyl analogues show promising antibacterial activity against multiple drug-resistant gram-positive and fastidious gram-negative bacteria, with potential for future clinical applications.

2001·29citations·C. Lee et al.·Bioorganic & medicinal chemistry

Bioorganic & medicinal chemistry

DOI: 10.1248/CPB.49.347

Structure-activity relationship (SAR) studies on oxazolidinone antibacterial agents. 1. Conversion of 5-substituent on oxazolidinone.

The antibacterial activity of 5-substituted oxazolidinones is greatly affected by the conversion of 5-substituent, with carbonyl oxygen and acetamido moiety affecting it, and thiocarbonyl sulfur enhancing it.

2001·29citations·Ryukou Tokuyama et al.·Chemical & pharmaceutical bulletin

Chemical & pharmaceutical bulletin

DOI: 10.1128/AAC.40.6.1508

In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections

U-100592 and U-100766 are potent oxazolidinone antimicrobial agents that effectively treat antibiotic-resistant gram-positive pathogens in experimental systemic and soft tissue infections.

1996·130citations·C. W. Ford et al.·Antimicrobial Agents and Chemotherapy

Antimicrobial Agents and Chemotherapy

Citations

DOI: 10.1002/open.202400432

Facile Synthesis of Oxazolidinones as Potential Antibacterial Agents.

This study developed a microwave-assisted synthesis method for novel oxazolidinone analogues, which showed promising antibacterial activity against M. smegmatis, using cheaper, less harsh commercial reagents.

2025·0citations·Secret P. Els et al.·ChemistryOpen

ChemistryOpen

DOI: 10.3390/molecules29061253

One-Step Construction of 1,3,4-Oxadiazoles with Anticancer Activity from Tertiary Amines via a Sequential Copper(I)-Catalyzed Oxidative Ugi/aza-Wittig Reaction

Copper(I)-catalyzed one-step synthesis of 1,3,4-oxadiazoles with anticancer activity from tertiary amines shows potential for synthesis and medicinal chemistry.

2024·0citations·Mei Sun et al.·Molecules

Molecules

DOI: 10.1016/j.molstruc.2023.135320

Synthesis, Structure Elucidation, Energy Frameworks, and DFT Calculations of 2,5-diphenyl-1,3,4-thiadiazole

2,5-diphenyl-1,3,4-thiadiazole is a novel thiadiazole derivative with a monoclinic crystal system and a R factor of 0.0360.

2023·8citations·K. Chandini et al.·Journal of Molecular Structure

Journal of Molecular Structure

DOI: 10.3390/ECSOC-24-08319

In silico Evaluation of Antimicrobial Activity of Some Thiadiazoles Using Molecular Docking Approach

Three 1,3,4-thiadiazole derivatives show better antimicrobial activity against Mycobacterium tuberculosis and Staphylococcus aureus DNA gyrase than natural ligands, with potential for further screening and design.

2020·2citations·A. Stefaniu et al.·Chemistry Proceedings

Chemistry Proceedings

DOI: 10.1016/j.bmcl.2020.127136

Synthesis of novel of 2, 5-disubstituted 1, 3, 4- oxadiazole derivatives and their in vitro anti-inflammatory, anti-oxidant evaluation, and molecular docking study.

Novel 2, 5-disubstituted 1, 3, 4-oxadiazole derivatives show promising anti-inflammatory and anti-oxidant activities, offering potential for structure-based drug design.

2020·34citations·B. Kashid et al.·Bioorganic & medicinal chemistry letters

Bioorganic & medicinal chemistry letters